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Abstract. Cyclin-dependent kinase complexes that 
contain the same catalytic subunit are able to induce 
different events at different times during the cell cycle, 
but the mechanisms by which they do so remain largely 
unknown. To address this problem, we have used affin- 
ity chromatography to identify proteins that bind spe- 
cifically to mitotic cyclins, with the goal of finding pro- 
teins that interact with mitotic cyclins to carry out the 
events of mitosis. This approach has led to the identifi- 
cation of a 60-kD protein called NAP1 that interacts 
specifically with members of the cyclin B family. This 
interaction has been highly conserved during evolution: 
NAP1 in the Xenopus embryo interacts with cyclins B1 
and B2, but not with cyclin A, and the S. cerevisiae ho- 
molog of NAP1 interacts with Clb2 but not with Clb3. 
Genetic experiments in budding yeast indicate that 
NAP1 plays an important role in the function of Clb2, 
while biochemical experiments demonstrate that puri- 
fied NAP1 can be phosphorylated by cyclin B/p34  ~c2 
kinase complexes, but not by cyclin A/p34  cd~2 kinase 
complexes. These results suggest that NAP1 is a protein 
involved in the specific functions of cyclin B/p34  cdc2 ki- 
nase complexes. In addition to NAP1, we found a 43- 
kD protein in Xenopus that is homologous to NAP1 
and also interacts specifically with B-type cyclins. This 
protein is the Xenopus homolog of the human SET 
protein, which was previously identified as part of a 
putative oncogenic fusion protein (Von Lindern et 
al., 1992). 
p 
ASSAgE through  the  eukaryotic  cell  cycle is  con- 
trolled by the activity of protein kinase complexes 
that  are composed of an activating subunit  (a cy- 
clin)  and  a  catalytic subunit  (a  cyclin-dependent  kinase 
[Cdk]l;  for reviews see Murray and Hunt, 1993; Norbury 
and Nurse, 1992). Cyclins were originally  identified as pro- 
teins  that  fluctuate  in  abundance  during  the  cell  cycle 
(Evans et al., 1983), while cyclin-dependent kinases were 
identified genetically as the products of genes required for 
cell cycle progression in yeasts (the CDC28 gene in S. cere- 
visiae  and  the  homologous  cdc2 gene  in  S.  pombe) 
(Hartwell et al., 1974; Nurse and Thuriaux, 1980). An ac- 
tive cyclin-dependent kinase complex was first identified 
biochemically  as  purified  maturation  promoting  factor 
(MPF), an activity from Xenopus eggs that can drive cells 
into mitosis and meiosis (Dunphy et al., 1988; Gautier et 
al., 1988; Lohka et al., 1988). 
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The cell cycle of the budding yeast S. cerevisiae is driven 
by a single cyclin-dependent kinase called p34  Cotes, which 
is activated during G1 by association with members of the 
G1 class  of cyclins  (encoded by three  CLN genes), and 
during S phase and mitosis by association with the B-type 
cyclins  (encoded by 6  CLB  genes)  (Epstein  and  Cross, 
1992; Nasmyth, 1993; Reed, 1992; Schwob and Nasmyth, 
1993). In vertebrate cells, the cell cycle is driven by a num- 
ber of related cyclin-dependent kinases (see for example, 
Meyerson et  al.,  1992).  One  of these,  called  p34  cdc2, is 
activated  during  mitosis  and  is  most  closely related  to 
p34  CDc2s from S. cerevisiae, while the other cyclin-depen- 
dent  kinases  appear  to  be  activated  during,  interphase. 
There  are  at  least five classes  of cyclins  in  vertebrates, 
called cyclins A, B, C, D, and E. Cyclin A appears during S 
phase, the B-type cyclins during mitosis, and cyclins D and 
E function during G1 (for reviews see Morgan, 1995; Pines, 
1993).  Recent  experiments  have  revealed  that  specific 
Cdk-cyclin complexes are also involved in the phosphory- 
lation of p34  cdcz and RNA polymerase, and in the regula- 
tion of phosphate metabolism in budding yeast, demon- 
strating  that these complexes can play a wide variety of 
roles in cell physiology (Fisher and Morgan,  1994; Kaff- 
man et al., 1994; Feaver et al., 1994; Roy et al., 1994). 
In budding yeast, activation of p34  ~dc28 by B-type cyclins 
during G2 induces mitotic spindle assembly and the other 
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induces such events as DNA replication and spindle pole 
body duplication. Thus, a key question concerns how ki- 
nase complexes that contain the same catalytic subunit are 
able to induce such different events at different times dur- 
ing the cell cycle. One possibility is that the many different 
kinds of cyclins serve to determine the specific functions of 
cyclin-dependent kinase complexes. A  number of experi- 
ments support the idea that the cyclin subunits determine 
the  functions  of  specific  cyclin-dependent  kinase  com- 
plexes. For example, cyclin A, but not cyclin B, is found in 
complexes that include the adenovirus E1A protein, the 
cellular transcription factor E2F, and an Rb-like protein 
called p107; and cyclin A is able to form kinase complexes 
that can bind and phosphorylate p107, while cyclin B is not 
(Nevins,  1992; Peeper  et  al.,  1993; Pines  and  Hunter, 
1990). Cdk4 can be activated by D  cyclins, but not by cy- 
clins A, B1, and E, and kinase complexes formed between 
Cdk4 and cyclins D2 or D3 can phosphorylate the Rb pro- 
tein, while complexes formed with cyclin D1 cannot (Kato 
et al., 1993). Sea urchin cyclin B induces the dramatic de- 
stabilization of microtubules that occurs as cells enter mi- 
tosis, while bovine cyclin A does not, even though the two 
cyclins activate H1 kinase activity to the same level (Verde 
et al., 1992). 
In contrast to these observations, a number of experi- 
ments have suggested that the different cyclins can per- 
form the same functions. For example, both cyclin A  and 
B  can induce Xenopus oocyte maturation, chromosome 
condensation, and nuclear envelope breakdown, and they 
both form kinase complexes that can phosphorylate his- 
tone H1 in a similar manner (Draetta et al., 1989; Minshull 
et al., 1990; Pines and Hunt, 1987; Swenson et al.,  1986; 
Westendorf et al.,  1989).  In addition, truncated forms of 
human cyclins A and B can rescue budding yeast cells that 
lack G1 cyclin function, suggesting that the different cy- 
clins share  considerable functional overlap  (Koff et  al., 
1991; Leopold and O'Farrell, 1991; Lew et al., 1991; Xiong 
et al., 1991). 
To learn more about potential functional differences be- 
tween the cyclins, we have used affinity chromatography 
to identify proteins that interact specifically with mitotic 
cyclins, with the goal of identifying proteins that mediate 
specific functions of cyclin-dependent kinase complexes. 
This  approach  reveals  that  an  evolutionarily conserved 
family of proteins interacts specifically with B-type cyclins. 
At least one member of this family is a specific substrate of 
cyclin B/p34  cdc2 kinase complexes and is required for the 
normal function of Clb2  in  budding yeast.  Our  experi- 
ments support the idea that cyclins can target the activity 
of  cyclin-dependent  kinases  to  specific  substrates,  and 
identify proteins  that may mediate  specific activities of 
B-type cyclins. 
Materials and Methods 
Reagents, Stock Solutions, and Media 
Luria-Beltrani media (LB)  and YPD  media are prepared  as described 
(Sambrook, 1989; No. 1499), and NZ media contains 20 g NZ amine, 10 g 
yeast extract, 5 gm casamino acids, and 5 g NaCI per liter. PMSF is made 
up as a  0.1-M stock solution in  100%  ethanol and is stored at  -20°C. 
PMSF is added to the Extract buffer just before lysis because it is unstable 
in water. DNAse I (Sigma Chem. Co., St. Louis, MO) is prepared as a 10- 
mg/ml stock solution in 50 mM Hepes, 50 mM KCI, 1 mM DTT, and 50% 
glycerol, and is stored at -20°C. Lysozyme (Sigma) is prepared as a 100- 
mg/ml stock solution in water, and is stored at -20°C. 
Buffers 
Phosphate buffered saline (PBS): 14 mM Na~HPO4, 1.8 mM KH2PO4, pH 
7.2,138 mM NaC1, 2.7 mM KC1. LPC Protease Inhibitor Mix: 1 mg/ml leu- 
peptin, 1 mg/ml pepstatin, 1 mg/ml chymostatin dissolved in dimethylsulf- 
oxide. Extract buffer: 50 mM Hepes-KOH, pH 7.6,  50 mM KCI, 1 mM 
MgC12, 1 mM EGTA, 1 mM PMSF, 1/1000  LPC Protease Inhibitor mix. 
Wash buffer: 50 mM Hepes-KOH, pH 7.6, 50 mM KCI, 1 mM MgC12, 1 
mM EGTA, 1 mM DTT,  10%  glycerol, 1/1,000  LPC protease inhibitor 
mix. Elution buffer:  50 mM Hepes-KOH, pH 7.6,  0.35  M  KCI,  1  mM 
MgClz, 1 mM EGTA, a  mM DTr,  1/1,000  LPC protease inhibitor mix, 
10% glycerol. Phosphorylation buffer: 75 mM Hepes-KOH, pH 7.6, 1 mM 
MgC12, 1 mM EGTA, 1 mM DT]?, 10% glycerol, 1/1,000 LPC protease in- 
hibitor mix, 0.25 mM ATP, 0.1 mCi/ml [~/32p] ATP (10 mCi/ml, 3,000 Ci/ 
mmol). Sample buffer: 65 mM Tris-HC1, pH 6.8, 3% sodium dodecyl sul- 
fate (SDS), 5% 13-mercaptoethanol, 10% glycerol. 
Purification of GST-Cyclin Fusion Proteins 
We express cyclins as glutathione-S-transferase (GST) fusions in E. coli 
using the vector pGEX.1 (Smith and Johnson, 1988).  For purification of 
GST-cyclins, bacterial  cells carrying a  particular  GST-cyclin expression 
construct are grown to saturation in approximately 400 ml of LB medium 
containing 100 mg/ml ampicillin. This culture is then used to inoculate 6 li- 
ters of NZ medium containing 100 mg/ml ampicillin. The culture is grown 
either at room temperature or 30~C until an optical density of approxi- 
mately one is reached, and the temperature of the culture is then reduced 
to room temperature, if necessary. IPTG is added to a concentration of 0.1 
mM, and the culture is incubated at room temperature for 3-4 h. The ceils 
are harvested by centrifugation, and washed once with 200 ml ice cold 
PBS and pelleted again. The cells are kept on ice during harvesting, and 
the final cell pellet is frozen on liquid nitrogen and stored at -80°C. 
For purification of GST-cyclins, the frozen cell pellet is thawed by the 
addition of 5 vol of PBS containing 1 mM EGTA, 1 mM EDTA, 1 mM 
PMSF,  0.1%  Tween  20,  and  200  mg/ml  lysozyme.  The  PMSF  and 
lysozyme are added to the buffer just before it is added to the ceils. The 
cell pellet is then stirred for approximately 30 min to break up the pellet 
and allow lysis to occur, and the ceils are then sonicated for several min- 
utes to further promote lysis. KC1 and DTF are added to the extract to fi- 
nal concentrations of 0.3 M and 15 mM, respectively. If the extract is fairly 
viscous at this point, DNAse I  and MgCIe are added to final concentra- 
tions of 10 rzg/ml and 2 mM, respectively. The extract is dialyzed against 
20 vol of PBS containing 0.3 M KCI for 45 min. This step is repeated a to- 
tal of three times. The dialysis step improves the yield of GST-cyclins ap- 
proximately twofold, possibly by removing free glutathione in the extract 
that competes with the glutathione on the column for binding of the GST 
fusion to the column. The extract is centrifuged at 100,000 g for 1 h and 
the supernatant is loaded onto a 5-10-mi glutathione agarose column at a 
rate of 5-10 column vol/h. The column is washed at a flow rate of 10 col- 
umn vol/h with PBS containing I mM DTT and 0.3 M KC1 until no protein 
can be detected in the fiowthrough (~15 column volumes). The column is 
eluted with 50 mM Tris  (pH  8.1),  0.3 M  KCI and 5  mM reduced glu- 
tathione (Sigma Chemical Co.), and the presence of protein in the elution 
fractions is determined by the Bradford assay (Bradford, 1976). The peak 
fractions are pooled  and dialyzed extensively into buffer containing 50 
mM Hepes (pH 7.6), 0.25 M KC1, and 30% glycerol. The yield of protein is 
between 15 and 50 rag, depending on the cyclin fusion protein. The puri- 
fied protein is frozen on liquid nitrogen and stored at -80°C. 
Construction of  Affinity Columns 
Affinity columns are constructed by coupling 4-6 mg of purified GST- 
cyclin fusion protein to 1 ml of Affigel 10 (Bio-rad Labs., Richmond, CA). 
The Affigel 10 is first washed several times with buffer (50 mM Hepes, pH 
7.6, 0.25 M  KC1) to remove the alcohol in which it is stored. The washes 
are carried out by resuspending the Affigel 10 beads in 10 vol of buffer, 
followed by sedimenting the beads in a table top centrifuge. After the Af- 
figel 10 beads have been washed, they are left on ice until 20 min have 
passed since the wash buffer was first added. This allows partial inactiva- 
tion of the beads (the  activated coupling sites on Affigel 10 beads are 
slowly inactivated by water) and prevents overcoupling of the protein to 
the beads. 1 ml of purified protein (at 4-6 mg/ml) is added to the Affigel 
10 beads, and the mixture is gently mixed on a rotator. The progress of the 
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measuring the protein concentration in the supernatant. When approxi- 
mately 80% of the input protein has been removed from the supernatant, 
the reaction is terminated by the addition of I M Tris (pH 8) to a final con- 
centration of 25 raM. The coupling reaction generally takes 10-60 min. 
The beads are transferred to a small column (we use a 3-ml syringe fitted 
with a  polypropylene disk at the bottom), and are washed with ehition 
buffer before being used in an affinity chromatography experiment. For 
storage, the columns are washed with buffer containing 100  mM Hepes 
(pH 7.6), 1 mM EGTA, 1 mM MgC12, 2 mM DTT, and 50% glycerol. The 
columns are stored at -20°C and can be reused three times without signif- 
icant changes in their properties. All of the steps described above are car- 
ried out at 4°C, except where noted. 
Columns containing BSA are made by adding 5 ml of a 10 mg/ml BSA 
solution to 5 ml of packed Affigel 10. The BSA solution is made up in 50 
mM Hepes, pH 7.6, and is dialyzed against the same buffer extensively be- 
fore being used to make columns. The BSA coupling reaction is started 
immediately after the Affigel 10 has been washed, and the reaction is al- 
lowed to proceed for at least 1 h at room temperature. BSA columns are 
washed with 50 mM Hepes (pH 7.6), 2 M  urea before use and between 
each use. The columns are stored at 4°C in PBS that contains 0.02% azide, 
and are reused many times. 
Affinity Purification of Yeast Cyclin-binding Proteins 
We use yeast cells arrested by nutrient depletion as the starting material 
for our experiments. Ceils are allowed to grow to saturation in YPD me- 
dia, and are harvested by centrifugation. The cells from several liters of 
culture are resuspended in 100 ml of 50 mM Hepes (pH 7.6), 50 mM KCI, 
and are then pelleted in 50-ml disposable conical tubes. The supernatant is 
removed, and a small hole is made in the bottom of the tube. The plunger 
from a 60-ml syringe is then used to force a thin stream of yeast out of the 
hole and directly into liquid nitrogen. This allows rapid freezing of the 
yeast paste. The frozen cells are stored at -80°C until needed. 
Yeast cells are broken open by grinding the frozen paste under liquid 
nitrogen with a mortar and pestle until a very fine powder is obtained (20- 
30 rain). For the experiment shown in Fig. 2 B, we used 15 grams of yeast 
cells as starting material. The powder is transferred to a small beaker and 
left at room temperature until it is just beginning to thaw. 35 ml of Extract 
buffer at room temperature is then added and the extract is stirred until a 
uniform solution is obtained. The extract is centrifuged at 40,000 rpm in a 
50.2Ti rotor for 1 h at 4°C and the supernatant is removed with a pipette, 
taking care to avoid particulate matter at the bottom of the tube. DTT is 
added to the supernatant to a final concentration of 1 raM. The protein 
concentration of the resulting supernatant is ~10 mg/ml. 
The extract is first passed through a  5-ml BSA column (see above). 
This serves as a prefllter to remove particulate matter and proteins that 
bind  nonspeciflcally to  the  affinity columns. The  BSA column is con- 
nected in series to the cyclin affinity column, such that the flowthrough 
from the BSA column flows directly onto the cycliu column. For the ex- 
periment shown in Fig. 2 B, we used a 1-ml Clb2 column and a 1-ml Clb3 
column, each having a BSA precolumn. The columns are preequilibrated 
with Extract buffer before loading the crude extract. The cyclin affinity 
columns are loaded at 8 column vol/h, and are then disconnected from the 
BSA precolumns and washed with 8 column volumes of Wash buffer at 8 
column vol/h. The columns are then ehited with Elution buffer and 0.25- 
ml fractions are collected. The elution is carried out by pipetting 0.25-ml 
aliquots of elution buffer directly onto the surface of the column bed. The 
elution buffer is then allowed to flowthrough the column by gravity and is 
collected  in  1.5-ml plastic tubes. The fractions are  assayed for protein 
qualitatively by mixing 5  }xl of each fraction with 45 p,l of Bradford re- 
agent on a piece of parafilm. The peak fractions are pooled and protein is 
precipitated by addition of TCA to a final concentration of 10% from a 
100%  (wt/vol) stock. After a  10-rain incubation on ice, the protein solu- 
tion is centrifuged for 10 min in a  microfuge, and the supernatant is re- 
moved. The tube is centrifuged again to remove the remaining liquid from 
the walls of the tube. The final supernatant is removed and the precipitate 
is resuspended in gel sample buffer, which is neutralized with the vapor 
from a cotton swab soaked in ammonium hydroxide. All steps are carried 
out at 4°C except where noted. The yield of protein from the Clb2 affinity 
column is ~25 }xg. 
Affinity Purification of Xenopus Egg 
Cyclin-binding Proteins 
Concentrated extracts from activated Xenopus eggs were made as previ- 
ously described (Murray, 1991). For the experiment shown in Fig. 2 A, 2.8 
ml of concentrated extract was diluted into 21 ml of Extract buffer. The 
diluted extract is centrifuged at 50,000 rpm in a 50Ti rotor for 100 rain. 
This unusually long spin is required to completely remove all ribosomes 
from the supernatant, because ribosomal subunits that remain in the su- 
pernatant will bind to the cyclin B columns and obscure the binding of the 
60-kD and 40-kD proteins. We do not know whether the binding of ribo- 
somes to the B-type cyclins represents a specific interaction, although the 
endogenous cyclin B in frog egg extracts has also been observed to bind to 
ribosomes (Leiss et al., 1992).  Our finding that yeast elongation factor la 
binds to Clb2 and Clb3 (Fig. 2 B, see the Results section) suggests that the 
binding of ribosomes to the Xenopus B cyclins may be due to an interac- 
tion with elongation factor let. The remainder of the experiment is carried 
out as described in the previous section for yeast cyclin affinity columns, 
except that the extract is loaded onto the affinity columns at 2 column vol/ 
h. The yield of protein from the cyclin B affinity columns is ~30 ~g. 
Immunoprecipitations 
To prepare beads for immnnoprecipitation experiments, 10 ~g of affinity 
purified antibody is mixed with 15 p,1 of protein A-Affigel 10 beads (Bio- 
tad Labs.) in PBS for 1 h at room temperature. The beads are then washed 
three times with 0.5 ml of 50 mM Hepes, 1 M NaC1, 0.05% Tween-20, fol- 
lowed by two times with Extract buffer. Yeast extracts are made from cells 
growing in log phase in YPD media, and the cells are broken open by 
grinding under liquid nitrogen as described above. For each 0.25 gm of 
yeast powder, 0.6 ml of Extract buffer is added, and the suspension is then 
centrifuged for 10 rain in a microfuge at 4°C. For each immunoprecipita- 
tion, 0.4 ml of extract is mixed with 15 pd of beads containing bound anti- 
body. The immunoprecipitations are mixed gently at 4°C for 2 h, and the 
beads are then washed four times with 100 vol of Wash buffer containing 
0.2 mM DTT. To wash the NAP1 off of the immunoprecipitated CLB2 
complexes, the beads are resuspended in 200 p.150 mM Hepes, 1 M NaCl, 
and 0.05% Tween-20. The beads are then pelleted, the snpernatant is re- 
moved carefully to avoid taking any beads, and the protein in the superna- 
taut is precipitated with TCA. This high salt wash allows us to separate the 
NAPI from the antibody bound to the beads, which would obscure the 
NAP1 band on Western blots. The precipitate is resuspended in 30 }xl of 
1X gel sample buffer, and 15 p,l is used for Western blotting experiments 
to detect NAP1. After the high salt wash, we boiled the beads in sample 
buffer to release the antibody, and used polyacrylamide gel electrophore- 
sis to confirm that equal amounts of Clb2 and Clb3 antibody were on the 
beads. 
Polyacrylamide Gel Electrophoresis, Western Blotting, 
and Protein Sequence Analysis 
Polyacrylamide gel electrophoresis and Western blotting were carried out 
as previously described (Anderson et al., 1973;  Harlow and Lane, 1988; 
Towbin et al., 1979).  For protein sequence analysis, cyclin-binding pro- 
teins were subjected to SDS-PAGE and electroblotted onto PVDF mem- 
brane  (Immobilon  P,  Millipore,  Bedford,  MA).  The  PVDF  blot  was 
stained with Ponceau S and the desired protein band was excised. The 
PVDF membrane carrying the protein was then destained, incubated with 
polyvinylpyrrolidone/MeOH to block protein-binding sites, and incubated 
with 1 p~g trypsin in 50 Ixl of 100 mM Tris-HCl, pH 8.0,  10% acetonitrile, 
and 1% Triton-X at 37°C for 24 h. Eluted tryptic peptides were subjected 
to reversed phase HPLC on a narrow bore column and individual peptides 
sequenced with an ABI gas-phase sequencer (model 475A). 
PCR Cloning of the SET cDNA from Xenopus 
and Drosophila 
We initially obtained a partial eDNA clone from the Xenopus SET gene 
using PCR primers based on the peptide sequences that we obtained from 
the protein (see Results). We then used a nested PCR reaction (Gibbons 
et al., 1991) to obtain the 5' end of the cDNA, using a Xenopus embryo 
plasmid cDNA library (gift of Jeremy Minshull) as template. To clone the 
Drosophila homolog of SET, we compared human SET with yeast NAP1 
and picked the regions of greatest homology as starting points for design- 
ing PCR primers. We eventually used the oligos AA(A/G) AT(A/C/T) 
CC(A/C/G/T)  AA(C/T)  TT(C/T)  TGG  and  (G/A)AA  CCA  (A/C/G/ 
T)GT  (G/A)AA  (G/A)AA  (A/C/G/T)(G/C)(T/A)  (C/T)TC(A/C/G/T) 
GG, corresponding to the peptides KIPNFW and PESFFTWF, for PCR 
reactions using a Drosophila embryo plasmid cDNA library (Brown and 
Kafatos, 1988) as template. This gave a fragment of the expected size that 
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tions to obtain the 5' and 3' ends of the cDNA. We used the VENT poly- 
merase (New England Biolabs, Beverly, MA) for the nested reactions, 
which should minimize the number of errors  due to misincorporation. 
Genbank accession number for the Drosophila SET cDNA is U30470. 
Deletion of the NAP1 Gene in S. cerevisiae 
An EcoR1-Rsal fragment of the NAP1 gene, a  Sall-Xhol fragment of 
the Leu2 gene (from the plasmid YEP13), and an Xhol-HindfII fragment 
of the NAP1 gene were successively  cloned in the EcoR1-Smal sites, Sall 
site and Sall-HindIII sites, respectively, of the multicloning sites in the 
pTZ19R vector. This construct was digested with Dral and Ndel and used 
for disrupting the NAP1 gene. The gene disruption was verified both by 
Southern blotting  and  by  immunoblotting for  the  NAP1  protein  with 
monoclonal and polyclonal antibodies. 
Purification of GST-Cyclin/p34 cat2 Complexes 
We purify activated cyclin/p34cdc2 complexes from Xenopus egg extracts 
according to a procedure modified from the one described by Solomon et 
al. (1990). Concentrated cytoplasmic extracts are made from electrically 
activated Xenopus eggs as previously described (Murray, 1991)  and ar- 
rested in interphase by the addition of cyclohexamide to 100 I~g/mL Puri- 
fied GST-cyclin A  or cyclin B is then added to the extract. A total of 300 
}xg of purified cyclin fusion protein is added to 0.8 ml of extract, but only 
about half of the total protein in the purified cyclins represents full-length 
GST-cyclin (see Fig. I). The extract is incubated at room temperature for 
20 min to allow binding of p34  cd¢2 and formation of an activated kinase 
complex, and is then diluted 1:1 with buffer containing 50 mM Hepes (pH 
7.6), 1 mM EGTA, 1 mM MgCl2, 1 M KCI, i mM PMSF and 1X LPC. The 
extract is centrifuged in a microfuge for 10 min before it is loaded onto a 
10-ml Biogel P4 desalting column (Biorad Labs.) equilibrated with buffer 
containing 50 mM Hepes (pH 7.6),  150 mM KCl, 1 mM EGTA, 1 mM 
MgC12, i  mM PMSF, 1:1,000 LPC protease inhibitor mix. 
The protein that flows through the column is pooled, brought to 5 ml by 
addition of the desalting column buffer, and centrifuged at 50,000 rpm in a 
70 Ti rotor for I h. The supernatant is loaded onto a 1-ml glutathione aga- 
rose column at 5 column vol/h, and the column is then washed with 5 col- 
umn vol of Wash buffer containing 1 M KC1, followed by 3 column vol of 
Wash buffer. The column is eluted in 0.25-ml fractions with 30 mM Tris 
(pH 8.1), 75 mM KC1,1 mM EGTA, i mM MgCI  2,10% glycerol, 5 mM re- 
duced glutathione. The fractions are assayed qualitatively for the presence 
of protein by the Bradford assay, and the peak fractions are pooled, ali- 
quoted, frozen on liquid nitrogen, and stored at -80°C. 
Phosphorylation of Xenopus NAP1 
The Xenopus NAP1 used for phosphorylation assays was further purified 
by ion exchange chromatography after the cyclin affinity column step. Cy- 
clin affinity chromatography is carried out as described above, except that 
the cyclin-binding proteins are eluted from the column in a buffer contain- 
ing 50 mM Tris-HCl, pH 8.1,350 mM NaCl, 1 mM MgC12, 10% glycerol, 
0.02% Tween-20,1 mM Dqq?, and LPC protease inhibitor mix. The eluted 
protein (approximately 150 p,g in 1.5 ml) is diluted to 2 ml with water and 
loaded onto a 0.4-ml column containing Q sepharose HP (Pharmacia) us- 
ing the Pharmacia Smart System. The column is equilibrated in 25 mM 
Tris-HCl, pH 8.1,250 mM NaCl, 0.5 mM MgC12, 1 mM DTT, 5% glycerol, 
0.02% Tween-20, and is eluted with a gradient starting at 250 mM NaC1 
and ending at 750 mM NaC1. The total volume of the gradient is 2 ml and 
100-pA fractions are collected. Virtually all of the contaminating proteins 
flowthrough the column under the load conditions, and NAP1 and SET 
begin to elute at ~0.4 M NaC1. A  10% polyacrylamide gel showing frac- 
tions from the NaCl gradient used to elute NAP1 from the Q  sepharose 
column is shown in Fig. 8 A. The SET protein elutes slightly later than 
NAP1. 
The fraction containing the most purified NAP1 (marked with an ar- 
row in Fig. 8 A) was used for phosphorylation experiments. Each phos- 
phorylation reaction contains 1.5 ~1 of the purified NAP1 (~4).3 ~g), 50 ixl 
of reaction buffer (50 mM Hepes-KOH, pH 7.6,  1 mM MgCl2,  1 mM 
EGTA, 10% glycerol, 0.01% Tween-20, 300 }xM ATP, 0.2 ~1 g32P-ATP 
[10 mCi/ml, 3,000 Ci/mmol]), and either 9 ~1 of purified cyclin A/p34  cdc2 
kinase or 4 pA of cyclin B1/p34  cdc2 kinase complex. The amount of each ki- 
nase used is determined empirically to give approximately equal amounts 
of phosphorylation of histone H1 under the same assay conditions. The 
reactions are allowed to proceed for 45 min at 25°C, and are terminated by 
addition of TCA to a final concentration of 10% from a 100% stock. The 
protein in the reactions is precipitated with TCA as described above, and 
the entire reaction is analyzed on a 10% polyacrylamide gel. 
Immunofluorescence 
Affinity purified rabbit polyclonal antibodies against NAPI were gener- 
ated using previously described methods (Harlow and Lane, 1988; Kellogg 
and Alberts,  1992).  Immunofiuoreseence staining with anti-NAP1  anti- 
bodies was carried out using previously described methods (Kilmartin et 
al., 1993; Pringle et al., 1991).  We obtained the same results whether we 
fixed the cells directly in 3.7% formaldehyde for 1 h, or fixed the cells for 5 
min in 3.7% formaldehyde after removal of the cell wall. 
Yeast Strains 
All biochemical experiments were carried out using the protease deficient 
strain FM135 (MATa gall, 1eu2-3,112 pep4-3 prbl-l122 regl-501 ura3-52), 
with the exception of the immunoprecipitation experiments, which were 
carried  out in the protease deficient strain JB811  (ura3-52, leu2-3,112, 
trpl, prbl, pep4-3). The strain carrying a  temperature sensitive allele of 
CLB2 in a  Clb2-dependent background is strain K3080 (MATa, Aclbl, 
clb2-ts, clb3::TRP1, clb4::HIS3 [Amon et al., 1993]).  The NAP1 gene was 
deleted in the W303 strain background (MATa ade2-1 trpl-1 1eu2-3,112 
his3-11,15 ura3 canl-lO0) to give strain DK96, and a strain carrying dele- 
tions of NAP1, CLB1, CLB3, and CLB4 was obtained by crossing DK96 
with strain K2652 (MATa, clbl::URA3, clb3::TRP1, clb4::HIS3) (Fitch et 
al., 1992).  We obtained five different spores carrying the quadruple dele- 
tion, and they all behaved identically. We also obtained the same pheno- 
type by directly knocking out the NAP1 gene in strain K2652. A  strain 
carrying deletions of CLN1 and CLN3 in the W303 strain background was 
made by backcrossing JO314-2C (MA Ta, clnl::TRP1, cln3::URA3, ade2-1, 
lys2, leu2, his3D200) into the W303 strain background three times. The re- 
sulting strain was then crossed with DK96 to give a strain carrying dele- 
tions for NAPI, CLN1, and CLN3. 
Results 
Identification  of Cyclin-binding Proteins 
We chose to use affinity chromatography to identify cy- 
clin-binding proteins, because this approach should allow 
detection of proteins that bind only weakly to cyclins, in 
addition to the proteins that bind tightly (for a theoretical 
discussion see Scopes, 1988; p. 72-90). To obtain amounts 
of cyclins sufficient for construction of affinity columns, 
we  expressed  cyclins  from  Xenopus  and  yeast  as  glu- 
tathione-S-transferase (GST) fusions in E. coli, and then 
purified the GST-cyclins by virtue of their affinity for glu- 
tathione  (Smith  and  Johnson,  1988).  Cyclin affinity col- 
umns were made by covalently linking the purified GST- 
cyclins to agarose beads. We have made affinity columns 
with cyclins A, B1, and B2 from Xenopus, and cyclins Clb2 
and Clb3 from the yeast S. cerevisiae. The purified fusion 
proteins used for construction of our affinity columns are 
shown in Fig. 1. All of the fusion proteins show some de- 
gree of proteolytic degradation and are slightly contami- 
nated  with  bacterial  proteins  of  apparent  molecular 
masses 60 and 70 kD. These are likely to be bacterial heat 
shock proteins. 
We carried out affinity chromatography experiments by 
loading columns with extracts made from either Xenopus 
eggs or yeast cells. After loading the extract, the columns 
were washed extensively and then eluted with 0.35 M KC1. 
Fig. 2 A shows the results of an experiment in which an in- 
terphase Xenopus embryo extract was loaded onto affinity 
columns containing the Xenopus  cyclins A, B1, and B2. 
Two prominent proteins of apparent molecular masses 40 
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cyclin fusion  proteins.  2 mg 
of each purified  GST-cyclin 
fusion  protein  was  loaded 
onto  a  10%  polyacrylamide 
gel.  Several  purified  fusion 
proteins  have major  break- 
down  products that  migrate 
at  about  25  kD.  These  are 
likely  to  correspond  to  the 
GST portion  of the  protein 
that has been clipped  off by 
endogenous proteases. 
kD and 60 kD are observed to bind to cyclins B1 and B2, 
but not to cyclin A. A  less prominent protein band at 90 
kD, and a group of proteins that migrate just below the 60- 
kD protein also bind to the B1 and B2 cyclins. There are a 
number of proteins that interact with all three cyclin affin- 
ity columns, but these proteins also bind to columns con- 
taining control GST fusion proteins (not shown), and we 
suspect that these are Xenopus proteins that interact with 
the  bacterial  heat  shock  proteins  that  contaminate  the 
GST fusion proteins. We have found no proteins that bind 
specifically to cyclin A  in this system. 
Fig.  2  B  shows  the  results  of a  similar experiment  in 
which an extract made from yeast cells arrested in G1  is 
loaded onto affinity columns containing Clb2 and Clb3. In 
this  experiment, proteins of apparent molecular mass 90 
kD and 60 kD bind Clb2, but not Clb3, while a protein of 
apparent molecular weight 50 kD binds to both Clb2 and 
Clb3. The amount of the 90-kD protein that binds to Clb2 
is somewhat variable, and the experiment shown in Fig. 2 
B gave an unusually high yield of the 90-kD protein. 
We wanted to determine whether there  are additional 
cyclin-binding proteins that are not released by the 0.35 M 
KC1 elution. For example, p34  cDc28 and a number of low 
molecular cyclin-dependent  kinase  inhibitor  proteins  in- 
teract very tightly with cyclins and can only be released by 
denaturing  conditions  (Dunphy et al.,  1988;  Mendenhall, 
1993; Zhang et al., 1993).  In our experiments, we have not 
been able to visualize such proteins directly because elu- 
tion  of the  cyclin  affinity columns  with  denaturants  re- 
leases approximately 100 mg of the  bound  cyclin and its 
breakdown products, which obscure proteins smaller than 
cyclin.  We  have,  however,  detected  the  presence  of 
p34  cDc28 in denaturing elutions by Western blotting, as ex- 
pected (data not shown). 
Figure 2.  (A)  Affinity  purification  of  cyclin-binding  proteins 
from Xenopus eggs. Cyclin-binding  proteins were affinity puri- 
fied, TCA precipitated,  and separated on a 10% polyacrylamide 
gel. The lane labeled Extract was loaded with 15 I~g of the high 
speed supernatant that was loaded onto the column.  The other 
lanes were loaded with the proteins that elute from cyclin affinity 
columns with 0.35 M KC1. The lanes labeled B1 cyclin and B2 cy- 
clin were loaded with 3 ~g of protein, whereas the A cyclin lane 
was loaded with an equivalent  amount of the elution from the A 
cyclin. The gel is stained with Coomassie blue. (B) Affinity purifi- 
cation of cyclin-binding proteins from S. cerevisiae. Cyclin-bind- 
ing proteins were affinity purified,  TCA precipitated, and sepa- 
rated on a 10% polyacrylamide gel. The lane labeled Extract was 
loaded with 15 ~g of the high speed supernatant that was loaded 
onto the column. The other lanes were loaded with the proteins 
that elute from CIb2 and Clb3 affinity columns with 0.35 M KC1. 
The lane labeled Clb2 was loaded with 3 Ixg of protein, whereas 
the Clb3 lane was loaded with an equivalent  amount of the elu- 
tion from the Clb3 affinity column. The gel is stained  with Coo- 
massie blue. 
A  Conserved Cyclin-binding Protein Interacts 
Specifically with B-Type Cyclins in Xenopus and Yeast 
To begin characterizing the proteins that interact with cy- 
clins, we used protein sequencing  techniques  to obtain a 
peptide  sequence  from the  60-kD  protein  that  interacts 
with Clb2. The peptide that we obtained (TYFYQK) was 
identical to a  sequence  of amino acids from a  previously 
described yeast protein called nucleosome assembly pro- 
tein 1 (NAP1). NAP1 was originally identified as a protein 
from HeLa cells  that  promotes nucleosome  assembly in 
vitro, and a  monoclonal antibody raised against the puri- 
fied HeLa cell protein was found to recognize proteins of 
similar molecular weight in yeast and Drosophila (Ishimi 
et al., 1984,  1985).  This monoclonal antibody was used to 
clone  the  yeast homolog of NAP1  (Ishimi and  Kikuchi, 
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yeast NAP1  in an affinity chroma- 
tography  experiment.  Fractions 
from the experiment shown in Fig. 
2 B  were separated on 10%  poly- 
acrylamide  gel, electroblotted onto 
nitrocellulose,  and  probed  with 
anti-NAP1  monoclonal  antibody. 
Lanes:  Crude extract, 15  Ixg; High 
speed supernatant, 15  t~g; Column 
flowthrough, 15 Ixg;  0.35 M KC1 elu- 
tion,  0.3  Ixg. (B) The behavior of 
Xenopus NAP1 in an affinity chro- 
matography experiment.  Fractions 
from the experiment shown in Fig. 
2 A  were separated on 10%  poly- 
acrylamide  gel, electroblotted onto 
nitrocellulose,  and  probed  with 
anti-NAP1  antibody.  Lanes:  Crude 
extract, 15 Ixg; High speed superna- 
tant, 15 ~g; Column flowthrough, 15 
~g; 0.35 M KCl elution (from a cy- 
clin B1 affinity column), 0.3 Ixg. 
1991).  Although NAP1 promotes nucleosome assembly in 
vitro, its role in this process in vivo remains unclear. 
We  used  the  monoclonal  antibody  that  recognizes 
NAP1 to confirm that the 60-kD protein that binds to Clb2 
is indeed NAP1. The Western blot in Fig. 3 A  shows that 
NAP1  is largely depleted from a  yeast extract as it flows 
over a Clb2 affinity column, as expected for a protein that 
interacts  specifically  with  Clb2.  When  an  extract  made 
from Anapl cells is passed over a Clb2 affinity column, the 
60-kD  band  is  no  longer present  (data  not  shown).  We 
next used the anti-NAP1 monoclonal antibody in a similar 
kind of Western blotting experiment to demonstrate that 
the 60-kD protein that interacts with the Xenopus cyclins 
B1 and B2 is the Xenopus homolog of NAP1 (Fig. 3 B). In 
Xenopus, the anti-NAP1 monoclonal antibody recognizes 
a  major protein of 60 kD, as well as a  number of minor 
proteins of lower apparent molecular weight. We initially 
suspected that these lower molecular weight proteins rep- 
resent proteolytic breakdown products or differently mod- 
ified  forms  of  NAP1.  However,  recent  experiments  in 
which we have used PCR to clone Xenopus homologs of 
NAP1  indicate  that there  are at least three  homologs of 
NAP1 in Xenopus (Kellogg, D. R., and A. W. Murray, un- 
published).  The  additional  protein  bands  may therefore 
represent different NAP1 homologs. 
To further confirm these results, we tested whether we 
could detect  an interaction  between the  endogenous  cy- 
dins and NAP1. For this experiment, we immunoprecipi- 
tated CLB2 and CLB3 from yeast extracts, and used West- 
ern  blotting  to  determine  whether  NAP1  coprecipitates 
with the cyclins (Fig. 4). The results further confirm that 
NAP1 interacts with CLB2, but not with CLB3. 
These  results indicate  that  the  specific interaction  be- 
tween NAP1 and B-type cyclins has been highly conserved 
during evolution.  In support of this, we have also found 
that Xenopus NAP1 interacts with budding yeast CLB2 in 
affinity  chromatography  experiments  (not  shown).  This 
high degree of conservation argues that the interaction be- 
tween NAP1  and  B-type cyclins is  biologically relevant, 
Figure  4.  NAP1  coprecipitates  with  the 
Clb2 protein. Immunoprecipitations were 
carried out as described  in the Materials 
and  Methods,  using  extracts  made from 
wild-type or Anapl cells. 
rather than the product of an artifactual in vitro associa- 
tion. Genetic evidence that the interaction between B-type 
cyclins  and  NAP1  is  biologically  relevant  is  presented 
below. 
The SET Protein, a NAPI Homolog, Binds to the 
Xenopus B-Type Cyclins 
To identify the 43-kD protein that binds to the Xenopus 
B-type cyclins, we obtained two tryptic peptide sequences 
(QPFFQLR and EFHLNESGDPS) from the protein and 
used these to design PCR primers for amplification of the 
coding  sequences.  We  initially  obtained  a  270-bp  DNA 
fragment that  encoded  an open reading frame and  then 
carried out further PCR reactions to obtain a larger clone 
that contains the 5' end of the cDNA. This partial cDNA 
encodes a 147-amino acid peptide that is 98% identical to 
the human SET protein (Von Lindern et al., 1992). Inter- 
estingly, the human SET protein is 25% identical to yeast 
NAP1  (Von  Lindern  et al.,  1992).  The  SET protein was 
originally identified as part of a putative oncogene formed 
by fusion of the SET gene to the CAN gene in a  case of 
acute  undifferentiated  leukemia  (Von  Lindern  et  al., 
1992).  This fusion results in the production of an mRNA 
that encodes  a  SET-CAN fusion protein,  and it remains 
unclear how this fusion protein might contribute to leuke- 
mogenesis. 
The high degree of conservation that we observed be- 
tween  human  and  Xenopus  SET  suggested  that  SET  is 
likely to be found in many organisms. As a  first step to- 
ward characterizing SET in other organisms, we used PCR 
to clone the Drosophila SET homolog. Human and Dro- 
sophila SET are 55%  identical,  confirming that SET is a 
highly conserved protein (Fig. 5). We have not yet found a 
SET homolog in yeast. 
The sequence of tryptic peptides obtained from the 50- 
kD protein that binds to both Clb2 and Clb3 (Fig. 2 B) in- 
Human  SET:  0 
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Figure 5. Comparison of the sequence  of the human and Droso- 
phila SET genes. Dashes indicate identical amino acids. 
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one of the most abundant proteins in yeast (Thiele et al., 
1985), it may be retained on the cyclin columns by a weak 
nonspecific affinity, and more work must be done to deter- 
mine whether this represents a biologically relevant inter- 
action. It is perhaps worth noting, however, that elonga- 
tion factor la binds to actin in a regulated manner and has 
microtubule severing activity, suggesting that it may play a 
more general role in cellular activities (Dharmawardhane 
et al., 1991; Shiina et al., 1994). 
NAP1 Plays an Important Role in Clb2 Function 
Since NAP1 interacts with Clb2, one would predict that it 
is  somehow involved in  Clb2  function.  Analysis  of Clb 
function in budding yeast is complicated by the fact that 
budding yeast have six different CLB genes that carry out 
overlapping functions, and as many as three of these genes 
can be deleted with little effect upon cell growth (Fitch et 
al., 1992; Kuhne and Linder, 1993; Richardson et al., 1992; 
Schwob and Nasmyth, 1993). Therefore, even if NAP1 is 
essential for Clb2 function, one might not expect to see 
any effect of deleting the NAP1 gene, since CLB2 itself is 
not  essential.  We  have  circumvented  this  problem  by 
studying NAP1 function in a strain that has been made de- 
pendent  upon  Clb2  for survival by  deleting the  CLB1, 
CLB3, and CLB4 genes. 
As  a  first step towards understanding NAP1  function, 
we deleted the NAP1 gene in a wild-type strain and in a 
strain that is dependent upon Clb2 for survival. Deletion 
of the NAP1 gene in a wild-type strain (w303 strain back- 
ground) has no obvious effect upon cell growth. Although 
the Anapl strain forms colonies at a normal rate, examina- 
tion of the cells reveals that they are often found in clumps 
of connected cells with elongated shapes (Fig. 6, A and B). 
Homozygous Anapl/Anapl  diploid cells also  exhibit ab- 
normal  morphology,  and  the  phenotype  appears  to  be 
somewhat stronger (data not shown). 
Deleting  NAP1  in  Clb2-dependent  cells  has  a  much 
more  dramatic  effect.  This  quadruple  deletion  strain 
( Anapl,  zaclbl, Aclb3, Aclb4) is temperature sensitive for 
growth at 38°C  (Fig. 7), and when grown at 30°C  forms 
large clumps of interconnected cells that have an unusual 
elongated morphology (Fig. 6, C and D). This phenotype 
is likely to be due to a defect in Clb2 function, since it is 
largely rescued by the  presence  of other  Clbs  that  can 
compensate for a defect in Clb2 function (e.g., Clbl, Clb3, 
and Clb4).  Several observations confirm this idea. First, 
the elongated morphology of these cells is quite similar to 
the morphology of cells that lack  Clbl,  Clb2,  Clb3, and 
Clb4, which form highly elongated buds because Clb func- 
tion is required to turn off polarized bud growth that is in- 
duced by the G1 cyclins (Amon et al., 1993; Fitch et al., 
1992; Kuhne and Linder, 1993; Lew and Reed, 1993; Rich- 
ardson et al., 1992; Schwob and Nasmyth, 1993).  Indeed, 
the morphology of the Anapl, Aclbl, Aclb3, Aclb4 cells is 
strikingly similar to that seen when cells dependent upon a 
temperature sensitive Clb2 are grown at a semirestrictive 
temperature (Fig. 6, E and F). Deletion of the NAP1 gene 
also causes a substantial increase in the temperature sensi- 
tivity of the clb2  ~ strain (Fig. 8). These observations indi- 
cate that Clb2 function is severely compromised in the ab- 
sence of NAP1. A detailed analysis of the role of NAP1 in 
Clb2 function is presented in the accompanying paper. 
Strains carrying deletions of NAP1  and  CLB2  have a 
phenotype that is similar to that of the quadruple deletion, 
but somewhat less severe. Because Aclb2 cells are largely 
dependent upon CLBI (Richardson et al., 1992; Surana et 
al., 1991), the observation that Aclb2, Anapl  cells have a 
phenotype suggests  that NAP1  also interacts with Clbl. 
Since Clbl and Clb2 are closely related proteins, this is not 
unexpected (Surana et al., 1991). 
To determine whether NAP1 might play a general role 
in  cyclin function, we  also  tested  the  effect of deleting 
NAP1 in a strain that is compromised for G1 cyclin func- 
tion. Wild-type yeast have three G1 cyclins, called CLN1, 
CLN2, and CLN3, and strains carrying deletions of CLN1 
and CLN3 are dependent upon CLN2 for survival. Dele- 
tion of NAP1 in such a Cln2-dependent strain has no obvi- 
ous phenotype, suggesting  that  NAP1  is  specifically in- 
volved in the functions of B-type cyclins. 
NAP1 Is Phosphorylated by Cyclin BIp34  ed~2 
Complexes, but Not by Cyclin Alp34  ~2 Complexes 
To induce the events of mitosis, cyclin-dependent kinase 
complexes are  likely to phosphorylate downstream sub- 
strates. To determine whether NAP1 might be such a sub- 
strate, we tested whether NAP1 can be phosphorylated by 
cyclin/p34  cdc2 kinase complexes in vitro. For these experi- 
ments, Xenopus  NAP1  eluted from a  cyclin affinity col- 
umn was further purified by ion exchange chromatogra- 
phy  (Fig.  9  A),  and  then incubated in  the  presence  of 
purified GST-cyclin B1/p34  ode2 complexes or  GST-cyclin 
A/p34  cdc2  complexes. The results are shown in Fig. 8 B. In- 
terestingly, we found that NAP1 is a substrate for cyclin B/ 
p34  cdc2 complexes, but not for cyclin A/p34  cd¢2 complexes. 
This is true even under conditions where cyclin A  and cy- 
din B  kinase  complexes phosphorylate histone  H1  to a 
similar extent. These results demonstrate that NAP1 is a 
specific substrate of cyclin B/p34  cdc2 kinase complexes, and 
lend support to the idea that cyclins can target the activity 
of p34  cat2 to specific substrates. We have not seen phos- 
phorylation of the SET protein in these assays. 
If  NAP1  is  specifically  phosphorylated  by  cyclin  B/ 
p34  cdc2 kinase complexes in vivo, one might expect to see 
an increase in the level of NAP1 phosphorylation during 
mitosis. To test this, we grew cells in the presence of 32p 
and arrested the cell cycle either in G1 phase using the 
mating pheromone alpha factor, or in mitosis using the mi- 
crotubule  inhibitor  benomyl.  We  then  immunoprecipi- 
tated NAP1 and determined the amount of phosphate in- 
corporated into NAP1 at the two different cell cycle stages 
by autoradiography. We found that NAP1 is phosphory- 
lated in vivo, but the total level of phosphate on NAP1 
does not  increase  significantly during  the  mitotic  block 
(not shown). This result does not rule out the possibility 
that phosphorylation of a specific site on NAP1 increases 
during mitosis, even though the bulk level of phosphoryla- 
tion does not change. 
NAP1 Is a Cytoplasmic Protein 
NAP1  was  originally identified as a  protein from HeLa 
cell extracts that promotes nucleosome assembly in vitro 
Kellogg et al. Cyclin-binding Proteins  667 Figure 6. The morphology of yeast cells that lack NAP1 or Clb function. Cells were grown to log phase in YPD media and photographed 
by phase contrast optics. A and B compare the morphology of wild-type cells and Dnapl cells, respectively. C and D  compare the mor- 
phology of zaclbl, Aclb3, Aclb4 cells and zanapl, Aclbl, zaclb3, Aclb4 cells. The cells in A-D were grown at 30°C. E  and F  show a strain 
carrying a temperature sensitive allele of CIb2 in a Clb2-dependent background  (Zlclbl, clb2-ts, clb3::TRP1,  clb4::HIS3)  grown at 23°C 
(E) or 3s.5°c (F). 
The Journal of Cell Biology, Volume 130, 1995  668 Figure 7.  Temperature sensitivity of yeast cells that carry dele- 
tions of the NAP1, CLB1, CLB3, and CLB4 genes. A series  of 
10-fold dilutions of each strain were spotted onto YPD plates and 
grown at 30°C or 38°C for 2-3 d. 
(Ishimi et al., 1984), and subsequent experiments indicate 
that NAP1 from yeast also has nucleosome assembly activ- 
ity (Ishimi and Kikuchi, 1991).  If NAP1  has a role in nu- 
cleosome assembly in vivo, one would predict that it has a 
nuclear localization. We therefore carried out immunoflu- 
orescence experiments to determine the subcellular local- 
ization of the NAP1 protein, using a strain carrying a dele- 
tion  of the  NAP1  gene as a  control (Fig.  10).  We found 
that NAP1  is primarily a  cytoplasmic protein. The strong 
cytoplasmic staining by anti-NAP1 antibodies made it dif- 
ficult to determine whether NAP1 is also in the nucleus; in 
some cells it appeared that NAP1 was excluded from the 
nucleus, whereas in other cells it appeared that there was 
some nuclear staining. In either case, the strong cytoplas- 
mic localization  of NAP1  indicates  that  it is  unlikely  to 
function only in nucleosome assembly. 
Discussion 
The Use of  Affinity Chromatography to Isolate Novel 
Cyclin-binding Proteins 
We have used  affinity chromatography to identify novel 
proteins  that  interact  specifically with B-type cyclins.  In 
budding  yeast, we  have found  two proteins  of apparent 
molecular masses 60 kD and 90 kD that bind to Clb2, but 
not to Clb3, whereas in Xenopus eggs we have found three 
proteins of apparent molecular masses 40,  60,  and 90 kD 
that bind to cyclins B1 and B2, but not to cyclin A. Since 
the GST-cyclins on the affinity columns bind p34  edcz from 
the extract, we do not know whether the proteins that we 
have isolated can bind to cyclin in the absence of p34  edc2' 
The  cyclin-binding  proteins  are  eluted  from the  affinity 
columns with 0.35 M KC1, which indicates that they inter- 
act with the cyclins with a relatively low affinity. For com- 
parison,  the  interaction  between  p34  cdc2 and  cyclin  can 
only be disrupted  with SDS,  and  other proteins that  are 
known to interact with cyclin/p34  cdc2 complexes also do so 
with a  relatively high affinity (Dunphy et al., 1988;  Men- 
denhall, 1993; Zhang et al., 1993). 
We have found no proteins that bind specifically to the 
Xenopus cyclin A or the yeast cyclin Clb3 under the condi- 
tions that we have used for our experiments. There are a 
number of possible reasons for this result. It may be that 
the proteins that interact with these cyclins are very rare, 
and we do not load enough extract onto our affinity col- 
umns to detect such proteins. Alternatively, these cyclins 
may require posttranslational modifications to bind to spe- 
cific proteins, and therefore fail to bind to the unmodified 
GST-cyclin on  our  columns.  It is  also  possible  that  the 
GST portion  of the  cyclin fusion protein  interferes with 
binding, or that the proteins that bind to these cyclins are 
insoluble  in  a  standard  cytoplasmic  extract.  Since  the 
GST-cyclin A  is able to activate H1 kinase activity and in- 
duce nuclear envelope breakdown and chromosome con- 
densation  in  Xenopus  egg  extracts  (data  not  shown),  it 
seems unlikely that it is incorrectly folded when expressed 
in bacteria. 
Cyclin A  in mammalian cells has been shown to interact 
with a number of proteins, including E1A, E2F, p107, p21, 
and PCNA (Cao et al., 1992; Devoto et al., 1992; Giordano 
et al.,  1989;  Peeper et al.,  1993;  Pines and Hunter,  1990; 
Zhang et al., 1993; Shirodkar, 1992).  Proteins such as p107, 
E1A,  and E2F are involved in transcriptional regulation. 
Since  little  transcription  occurs  before  the  midblastula 
transition these proteins are unlikely to interact with regu- 
latory factors such as cyclin A  in the early Xenopus em- 
bryo. This idea is supported by the finding that the E2F 
present in early Xenopus embryos is not  associated with 
the  proteins  that  bind  to  it  in  postembryonic cell cycles 
(Philpott and Friend,  1994).  The interaction between cy- 
clin A  and proteins such as p21 and PCNA is stable to at 
least 0.6  M  NaC1,  and  such tight-binding proteins would 
not be eluted from the column under the conditions that 
we have used (0.35 M KC1). 
Figure 8. Deletion of the NAP1 gene increases the temperature sensitivity of a clb2  ts strain. A series of 10-fold dilutions of each strain 
were spotted onto YPD plates and grown at 23°C, 30°C, 34°C, or 37°C. 
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specifically  phosphorylated 
by  cyclin  B/p34  cd¢2  kinase 
complexes. (A) Further puri- 
fication of NAP1 by ion ex- 
change  chromatography  on 
Q  sepharose.  The  elution 
from  a  Xenopus B1  cyclin 
column was loaded onto a Q 
sepharose column and eluted 
with a salt gradient. This gel 
shows the fractions from the 
salt gradient elution that con- 
tain  NAP1  and  SET.  The 
fraction containing the most 
purified NAP1 (marked with 
an  arrow  at  the  top  of the 
gel) was  used  for the phos- 
phorylation  reactions.  (B) 
Phosphorylation  of  NAP1 
by  cyclin  B/p34  cac2  com- 
plexes.  Reactions  were  car- 
ried out as described in Ma- 
terials and Methods, and each reaction was analyzed by polyacrylamide gel electrophoresis and autoradiography. The contents of each 
reaction are indicated at the top of the gel. (C) The same fractions from the Q sepharose column shown in A were probed with the anti- 
NAP1 monoclonal antibody. (D) The same fractions from the Q sepharose column shown in A were used in the phosphorylation assay 
with cyclin B/p34  ¢dc2 complexes. These results show that the protein being phosphorylated by cyclin B/p34  cat2 copurifies with NAPI. 
The NAPISET Family of Proteins Interact Specifically 
with B-Type Cyclins 
We have shown that the 60-kD protein that binds to Clb2 
is identical to a  previously described yeast protein called 
NAP1. A  monoclonal antibody that recognizes NAP1 ho- 
mologs in many species (Ishimi et al., 1985) allowed us to 
determine that  the Xenopus  homolog of NAP1  binds to 
cyclins B1 and B2, but not to cyclin A. These results indi- 
cate that the interaction between B-type cyclins and NAP 
proteins has been highly conserved during evolution. 
We also obtained a  partial cDNA clone for the 40-kD 
protein that binds to the Xenopus  B-type cyclins. The se- 
quence of this partial cDNA reveals that it is the Xenopus 
homolog of the human SET protein, which is ~25 %  iden- 
tical to yeast NAP1. The SET gene was initially identified 
as part of a putative oncogene formed by the fusion of the 
CAN gene with the SET gene in a  case of acute myeloid 
leukemogenesis (Von Lindern et al., 1992). This fusion re- 
suits in production of a chimeric mRNA including most of 
the SET gene fused to the CAN gene. Since the CAN pro- 
Figure 10.  The  cytoplasmic 
localization of NAP1 in yeast 
ceils. The localization of the 
NAP1  protein  was  deter- 
mined using an affinity puri- 
fied  polyclonal  antibody, 
while  the  distribution  of 
DNA in  the  same  cells was 
determined  with  DAPI 
stain.  (A) NAP1  staining of 
wild-type  haploid cells. (B) A 
control showing NAP1 stain- 
ing in Anapl cells. C  and D 
show  DNA  staining  in  the 
same cells shown in A and B, 
respectively.  The  scale  bar 
represents 10 microns. 
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(Von Lindern et al., 1992), it is not clear that the SET pro- 
tein plays any direct role in leukemogenesis. An intriguing 
possibility suggested by our results is that fusion to SET 
targets the CAN protein for inappropriate phosphoryla- 
tion by cyclin B/p34  cdc2 kinase complexes. 
Our sequence of Drosophila SET indicates that SET is a 
highly conserved protein, being 55 % identical between hu- 
mans and Drosophila. The SET protein is found primarily 
in  the  nucleus of HeLa cells  and is phosphorylated on 
serine in vivo (Adachi, 1994). Analysis of the expression of 
SET mRNA in mouse tissues revealed that it is expressed 
in a wide variety of tissues and at very high levels during 
embryogenesis. In addition, DNA probes to the 3' end of 
the  SET  coding  sequences  detect  at  least  10  different 
cross-hybridizing bands on a genomic Southern blot, indi- 
cating that the SET gene may be part of a large multigene 
family (Von Lindern et al., 1992). Additional proteins re- 
lated to NAP1  and SET have been identified in human 
(Simon et al., 1994),  mouse (PIR protein database num- 
bers JS0707  and $16863),  sea urchin (Genbank number 
D21877), C. elegans (Genbank number T01616),  Plasmo- 
dium falciparum  (Lenstra et al.,  1987),  and Arabidopsis 
thaliana (Genbank numbers T20922 and U12858).  In addi- 
tion,  our  preliminary PCR  experiments  have  indicated 
that there are at least three different NAP1 homologs in 
Xenopus, indicating that NAP1 and SET are members of a 
growing family of related proteins. 
The In Vivo Function of NAP1 
NAP1 was originally identified as a protein in HeLa cell 
extracts that will promote the assembly of nucleosomes 
onto naked plasmid DNA in vitro (Ishimi et al., 1984). The 
purified protein was given the name NAP1  (nucleosome 
assembly protein  1),  and  a  monoclonal antibody raised 
against it was found to recognize a protein of similar mo- 
lecular weight in Drosophila and yeast (Ishimi et al., 1985). 
This antibody was used to clone the S. cerevisiae homolog 
of NAP1, which was also found to promote nucleosome 
assembly in  vitro  (Fujii-Nakata et  al.,  1992; Ishimi and 
Kikuchi, 1991). The relevance of NAPI's ability to drive 
nucleosome assembly in vitro to its in vivo function is un- 
clear. We found that yeast NAP1 is primarily a cytoplas- 
mic protein, and similar results have been obtained in ver- 
tebrate  cells  (Kikuchi,  A.,  unpublished  results),  The 
cytoplasmic localization of NAP1  suggests that it is  un- 
likely to function solely in nucleosome assembly, as such a 
protein would be expected to be found primarily in the nu- 
cleus. 
The  results  presented  here  demonstrate  that  NAP1 
plays an important role in the function of the yeast mitotic 
cyclin Clb2. We have studied NAP1  function in a  yeast 
strain that is dependent upon CLB2 for survival, which can 
be generated by deletion of the genes for additional mi- 
totic cyclins that share functional overlap with Clb2 (i.e., 
Clbl, Clb3, and Clb4). When NAP1 is deleted in a Clb2- 
dependent strain, the cells become temperature sensitive 
and grow as large clumps of highly elongated cells. This 
phenotype is similar to the phenotype of cells that partially 
lack Clb function, and it is largely rescued by the presence 
of other Clbs that can compensate for defects in Clb2 func- 
tion. In addition, deletion of the NAP1 gene substantially 
increases the temperature sensitivity of a strain that is de- 
pendent  upon  a  temperature  sensitive  allele  of CLB2. 
Taken  together,  these  observations  demonstrate  that 
NAP1 is somehow required for proper function of Clb2, 
and a more detailed analysis of the role of NAP1 in Clb2 
function is presented in the accompanying paper. 
The Substrate Specificity of Cyclin-dependent 
Kinase Complexes 
Many kinases are known to have overlapping or identical 
substrate specificities when tested in vitro. For example, 
cyclin-dependent kinases, the MAP kinase family, and gly- 
cogen synthase kinase 3 have overlapping substrate speci- 
ficities in vitro (Nigg, 1991; Peter et al., 1992; Plyte et al., 
1992). It seems unlikely, however, that these kinases phos- 
phorylate the same substrates in vivo. What determines 
the substrate specificities of protein kinases inside ceils? 
The multiplicity of protein kinases and their importance in 
virtually every aspect of cellular regulation highlight the 
importance of this question. The finding that NAP1 is a 
specific substrate of cyclin B/p34  ede2 complexes is there- 
fore of particular interest,  as  it may provide  important 
clues towards understanding kinase specificity. 
Several models might explain how NAP1 is phosphory- 
lated specifically by cyclin B/p34  ede2 complexes. Binding of 
NAP1  to  the  cyclin B/p34  cat2 complex  might induce  a 
conformational change in NAP1 that exposes a phosphor- 
ylation site,  or NAP1  might be  sterically blocked from 
occupying the active site of p34  edc2 in cyclin A/p34  cat2 com- 
plexes.  Another possibility is  that NAP1  is  a  relatively 
poor  substrate  for  cyclin-dependent  kinases,  and  that 
binding to cyclin B increases the effective local concentra- 
tion of NAP1 and drives the reaction. A less likely hypoth- 
esis is that the substrate specificity of the catalytic site on 
p34  ~dc2 is actually different in cyclin A  or cyclin B/p34  cdc2 
complexes.  In  this  view,  binding of cyclin B  to  p34  ~dc2 
would induce a conformational change in p34  ~a~2 that cre- 
ates an active site that can accommodate NAP1, whereas 
binding of cyclin A does not. 
Perhaps  there  are  two kinds  of substrates  for cyclin- 
dependent kinases. One kind of substrate can be phosphor- 
ylated by multiple cyclin-dependent kinase complexes (e.g., 
histone H1 or nuclear lamins), while another class can be 
phosphorylated only by specific cyclin-dependent kinase 
complexes (e.g., NAP1 and p107).  It is also possible that 
proteins like histone H1 and nuclear lamins are not in vivo 
substrates  of cyclin-dependent kinases.  Indeed, the  evi- 
dence that histone H1 and nuclear lamins are phosphory- 
lated by cyclin-dependent kinases in vivo remains circum- 
stantial, as it is very difficult to prove conclusively that a 
particular protein is phosphorylated by a particular kinase 
in vivo. 
The Specific Functions of Cyclin-dependent 
Kinase Complexes 
One might imagine two general models that could explain 
how cyclin-dependent kinase complexes are able to induce 
different events at different times of the cell cycle. One 
model would suggest that certain substrates are competent 
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particular times during the cell cycle. For example,  there 
may be a  mechanism  that causes  certain proteins to un- 
dergo a posttranslational modification at the end of mito- 
sis that renders them competent to be phosphorylated by 
cyclin-dependent  kinases  during  G1.  Other  mechanisms 
would reverse this modification at the end of S phase, and 
cause  the  modification  of a  new  group  of proteins  that 
could  make  them  competent  to  be  phosphorylated  by 
cyclin-dependent kinases at the beginning of mitosis. One 
way of regulating phosphorylation at  the substrate  level 
would be the existence of specific phosphatases that were 
only active  at certain points in the cell  cycle,  and would 
thus  prevent  the  accumulation  of  phosphate  groups  on 
some  substrates.  In this view,  the primary differences  in 
cyclins would involve differences in regulation that deter- 
mine when they are activated. The finding that expression 
of truncated forms  of human cyclins A, B,  C,  D,  and E 
during G1 can rescue yeast cells that lack G1 cyclins sug- 
gests that any cyclin that can activate p34  cdc28 kinase activ- 
ity is sufficient to get cells through G1 (Lew et al., 1991). 
On the other hand, the finding that expression of G1 cy- 
clins during G2 can induce G1 events, and vice versa (Lew 
and Reed,  1993) suggests that different cyclins can induce 
specific events independent of the time during the cell cy- 
cle and argues against a substrate availability model. The 
ability  of heterologous  cyclins  to  rescue  yeast  cells  that 
lack G1 cyclin activity may reflect the ability of the exoge- 
nous cyclins  to induce  expression  of other yeast cyclins, 
such as Clb5 and Clb6, that can induce events downstream 
of Start. 
An alternative model is that the different cyclins act to 
determine  the  specific  functions  of cyclin-dependent ki- 
nase complexes. The cyclins could do this by targeting the 
activity of cyclin-dependent kinase complexes  to specific 
substrates.  Our  results  support  this  kind  of model.  We 
found that NAP1 interacts specifically with B-type cyclins 
and is phosphorylated by cyclin B/p34  cdc2 complexes,  but 
not by cyclin A/p34  cdc2 complexes,  clearly indicating that 
the cyclin subunit can target the kinase activity of p34  cdc2. 
In  addition,  we  show  in  the  accompanying  paper  that 
NAP1 plays an important role in the specific functions of 
CLB2/p34 cdc28 kinase complexes  in yeast cells. An ability 
of the cyclin subunit to target the activity of cyclin-depen- 
dent kinases has also been observed in the phosphoryla- 
tion of p107 and Rb (Kato et al., 1993; Peeper et al., 1993). 
These results may provide a starting point for understand- 
ing how different  cyclin-dependent kinase complexes  are 
able to induce different  cell cycle events.  It seems  likely 
that cells may use several mechanisms to induce different 
cell cycle events at different times, including the regulation 
of substrate availability and the targeting of p34  cdc2 to spe- 
cific substrates. 
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